The Blue Jet Healthcare IPO commenced on October 25, 2023, and concluded on October 27, 2023. The allotment of shares took place on November 1, 2023, and the initiation of refunds began on November 1, 2023. The shares were credited to the demat accounts of investors on November 3, 2023. Finally, the listing of Blue Jet Healthcare on the stock exchange occurred on November 6, 2023.
The Blue Jet Healthcare IPO was priced at ₹329 to ₹346 per share, with a lot size of 43 shares. The total issue size was ₹840.27 crores, comprising a offer for sale of ₹840.27 crores. The IPO was listed on both the NSE and BSE.
In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 50% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 35% of the shares.
Blue Jet Healthcare IPO Basic Details
| Company Name | Blue Jet Healthcare Limited |
| Domain of Company | Pharmaceutical and Healthcare Ingredient Company |
| Blue Jet Healthcare IPO GMP Today | ₹63 |
| Blue Jet Healthcare IPO Listing Gain | 18.21% |
| Blue Jet Healthcare IPO Open Date | October 25, 2023 |
| Blue Jet Healthcare IPO Close Date | October 27, 2023 |
| Blue Jet Healthcare IPO Allotment Date | November 1, 2023 |
| Blue Jet Healthcare IPO Listing Date | November 6, 2023 |
| Face Value | ₹10 per share |
| Price | ₹329 to ₹346 per share |
| Lot Size | 43 Shares |
| Issue Size | 24,285,160 shares of ₹2 (aggregating up to ₹840.27 Cr) |
| Offer for Sale | 24,285,160 shares of ₹2 (aggregating up to ₹840.27 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE, BSE |
| Company Promoters | Akshay Bansarilal Arora, Shiven Akshay Arora and Archana & Akshay Arora |
Blue Jet Healthcare IPO GMP Today:
| Date | GMP | Listing Gain | Kostak | Subject to |
| Today | ₹63 | 18.21% | – | – |
| 24 October 2023 | ₹63 | 18.21% | – | – |
Blue Jet Healthcare Limited IPO Details:
Blue Jet Healthcare, established in 1968, is a company that specializes in pharmaceuticals and healthcare ingredients. They were the first to produce artificial sweeteners, like saccharin and its salts, in India. Over time, they expanded into making contrast media intermediates, which are essential for CT scans and MRIs. The company primarily focuses on three product categories: contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and active pharmaceutical ingredients.
Blue Jet Healthcare is a global pharmaceutical company driven by science. They offer services such as process development, production capabilities, worldwide regulatory support, and collaboration for the development and manufacturing of advanced pharmaceutical intermediates and APIs. The company operates from three manufacturing facilities located in Shahad (Unit I), Ambernath (Unit II), and Mahad (Unit III) in the state of Maharashtra, India. As of June 30, 2023, these facilities have annual production capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively.
Blue Jet Healthcare IPO More Details Click Here
Blue Jet Healthcare IPO FAQs
When is Blue Jet Healthcare IPO open?
Blue Jet Healthcare IPO will open on 25 October 2023.
When is Blue Jet Healthcare IPO Close?
Blue Jet Healthcare IPO will be closed on 27 October 2023.
What is Blue Jet Healthcare IPO GMP Today?
The Blue Jet Healthcare IPO GMP aka Grey Market Premium is ₹63.
What is Blue Jet Healthcare IPO Kostak Rates Today?
The Blue Jet Healthcare IPO Kostak Rate is ₹000.
What is Blue Jet Healthcare IPO Subject to Sauda Price Today?
The Blue Jet Healthcare IPO subject to sauda rates is ₹000.
Blue Jet Healthcare IPO Expected Returns?
The Blue Jet Healthcare expected return is 18.21%.
How much will be the listing gain in Blue Jet Healthcare IPO?
Blue Jet Healthcare IPO will get listing gain of 18.21%. (Approx.)
